Form 4: Medpace Holdings Director Acquires Shares

Cornelius P. McCarthy III, a Director at Medpace Holdings, Inc., acquired 29 shares of common stock on March 31, 2026, through the vesting of restricted stock units.

Summary

• Cornelius P. McCarthy III, a Director of Medpace Holdings, Inc., acquired 29 shares of common stock.
• The acquisition occurred on March 31, 2026.
• These shares were acquired through the vesting of restricted stock units (RSUs).
• Following this transaction, Mr. McCarthy beneficially owns 10,324 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The acquisition of a small number of shares by a director through RSU vesting is a standard compensation practice and does not inherently signal a significant change in the company's outlook.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Vesting of RSUs indicates continued employee/director engagement and reward for service.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition by a director, are common in the contract research organization (CRO) industry as a form of compensation and incentive alignment. Medpace Holdings operates within this sector, providing outsourced clinical research services to the pharmaceutical and biotechnology industries.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively as a sign of commitment, though the small number of shares is unlikely to have a significant impact on the stock price.

Key Dates

Keywords

Medpace Holdings, MEDP, Form 4, Insider Trading, Stock Acquisition, Restricted Stock Units, Director, Beneficial Ownership